Ann: Change of Director's Interest Notice, page-50

Yes Mauricio your right it’s been a disappointing few years for Meso but to say they have zero results is totally wrong and misleading.Suggest you read their last financial report which shows Revenue of 10.2 million, an increase of 37% over the previous year. All thanks to Japan who believe that saving lives is worthwhile and important. Based on Japans population we are only targeting 1.6% of the World market. . Also worth noting that we only receive royalties from Japan and that’s just for the treatment of aGHVD for both Children and Adults under the Temcel brand. The potential is massive but relies on the FDA doing the right thing. This has never been about zero results. This has always been about the FDA making Meso jump through more and more hoops with total disregard for the children dying. An absolute disgrace. Still impossible to understand how the ODAC voted 9-1 and the FDA rejected the science. Has always smelled of corruption at the highest level. And I can say that confidently due to the success of Temcel (since 2016) in Japan.Something is clearly not right at the FDA..